Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-11-007921
Filing Date
2011-02-14
Accepted
2011-02-14 06:17:19
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v211077_10ka.htm 10-K/A 4488830
2 GRAPHIC pg40.jpg GRAPHIC 45593
3 v211077_ex10-26.htm EX-10.26 49458
4 v211077_ex23-1.htm EX-23.1 4757
5 v211077_ex31-1.htm EX-31.1 19709
6 v211077_ex31-2.htm EX-31.2 16691
7 v211077_ex32-1.htm EX-32.1 6485
8 v211077_ex32-2.htm EX-32.2 6775
  Complete submission text file 0001144204-11-007921.txt   4657121
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-13441 | Film No.: 11601991
SIC: 2836 Biological Products, (No Diagnostic Substances)